Leukocyte activation induces aryl hydrocarbon receptor up-regulation, DNA binding, and increased Cyp1a1 expression in the absence of exogenous ligand

被引:57
作者
Crawford, RB
Holsapple, MP
Kaminski, NE
机构
[1] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA
[2] Michigan State Univ, Dept Pathol, E Lansing, MI 48824 USA
[3] Dow Chem Co USA, Toxicol Res Lab, Midland, MI 48674 USA
关键词
D O I
10.1124/mol.52.6.921
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aryl hydrocarbon receptor (AhR) functions as a transcription factor after ligand binding by halogenated aromatic hydrocarbons. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), the most toxic halogenated aromatic hydrocarbon, is dependent on binding to the AhR to mediate a broad range of toxic effects. Immune suppression is one of the most sensitive sequela associated with TCDD exposure, yet, paradoxically, resting leukocytes express a relatively low amount of AhR. Here we report that activation of leukocytes produced a 6-fold increase in AhR steady state mRNA levels and a concordant increase in AhR protein expression. Furthermore, leukocyte activation induced AhR translocation, DNA binding to a dioxin response element, and CYP1A1 transcription in the absence of TCDD. Activated leukocytes exhibited an even greater enhancement of dioxin response element binding by the AhR in the presence of TCDD than in the absence of TCDD. These studies suggest that the mechanism responsible for the sensitivity of immunocompetent cells to TCDD may be directly associated with a marked increase in AhR expression, which accompanies leukocyte activation.
引用
收藏
页码:921 / 927
页数:7
相关论文
共 23 条
  • [1] TISSUE-SPECIFIC EXPRESSION OF THE RAT AH-RECEPTOR AND ARNT MESSENGER-RNAS
    CARVER, LA
    HOGENESCH, JB
    BRADFIELD, CA
    [J]. NUCLEIC ACIDS RESEARCH, 1994, 22 (15) : 3038 - 3044
  • [2] Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor
    Chen, YH
    Tukey, RH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (42) : 26261 - 26266
  • [3] DENISON MS, 1988, J BIOL CHEM, V263, P17221
  • [4] EXPRESSION OF AH RECEPTOR (TCDD RECEPTOR) DURING HUMAN MONOCYTIC DIFFERENTIATION
    HAYASHI, S
    OKABEKADO, J
    HONMA, Y
    KAWAJIRI, K
    [J]. CARCINOGENESIS, 1995, 16 (06) : 1403 - 1409
  • [5] HOLSAPPLE MP, 1991, ANNU REV PHARMACOL, V31, P73
  • [6] RESULTS OF A 2-YEAR CHRONIC TOXICITY AND ONCOGENICITY STUDY OF 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN IN RATS
    KOCIBA, RJ
    KEYES, DG
    BEYER, JE
    CARREON, RM
    WADE, CE
    DITTENBER, DA
    KALNINS, RP
    FRAUSON, LE
    PARK, CN
    BARNARD, SD
    HUMMEL, RA
    HUMISTON, CG
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1978, 46 (02) : 279 - 303
  • [7] Ma Q, 1996, MOL CELL BIOL, V16, P2144
  • [8] DIRECT EFFECTS OF 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD) ON RESPONSES TO LIPOPOLYSACCHARIDE (LPS) BY ISOLATED MURINE B-CELLS
    MORRIS, DL
    KARRAS, JG
    HOLSAPPLE, MP
    [J]. IMMUNOPHARMACOLOGY, 1993, 26 (02): : 105 - 112
  • [9] NOVAK U, 1995, BIOTECHNIQUES, V19, P54
  • [10] 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN AND RELATED HALOGENATED AROMATIC-HYDROCARBONS - EXAMINATION OF THE MECHANISM OF TOXICITY
    POLAND, A
    KNUTSON, JC
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1982, 22 : 517 - 554